½ÃÀ庸°í¼­
»óǰÄÚµå
1321020

ÇÇÀӱⱸ ½ÃÀå : ¼¼°è »ê¾÷ ±Ô¸ð, Á¡À¯À², µ¿Çâ, ±âȸ, ¿¹Ãø(2017-2027³â)

Contraceptive Devices Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Product Type, By Distribution Channel, By End User, By Region

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: TechSci Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 112 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°èÀÇ ÇÇÀÓ¾à ½ÃÀåÀº 2027³â±îÁö ³î¶ó¿î ¼Óµµ·Î ¼ºÀåÇÒ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù.

»ç¶÷µéÀº »ý½Ä±â¸¦ ÅëÇØ Àü¿°µÇ´Â ÀӽŰú °¨¿°À» ÇÇÇϱâ À§ÇØ ÇÇÀӱⱸ¸¦ »ç¿ëÇÕ´Ï´Ù. ½ÃÁß¿¡¼­ º¼ ¼ö ÀÖ´Â ÇÇÀӱⱸ¿¡´Â ĸ, º¹ÇÕ ÇÇÀÓ¾à, ÇÇÀÓ ÀÓÇöõÆ®, ´ÙÀ̾îÇÁ·¥, Áú ¸µ, Àڱó» Àåºñ, Äܵ¼ µîÀÌ ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÇÇÀӱⱸ´Â ³²¼º¿ë°ú ¿©¼º¿ëÀÌ ÀÖ½À´Ï´Ù. ÇÇÀӱⱸ´Â Á¤ÀÚ°¡ Àڱÿ¡ Á¢ÃËÇÏ´Â °ÍÀ» ¸·´Â ¹°¸®Àû Àå¾Ö¹° ¿ªÇÒÀ» ÇÕ´Ï´Ù. À̸¦ ÅëÇØ ¼öÁ¤À» ¾ïÁ¦ÇÏ°í °¨¿° À§ÇèÀ» ÁÙÀÌ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ¼ºº´ À¯º´·ü Áõ°¡¿Í Àα¸ °úÀ× ¾ïÁ¦¿¡ ´ëÇÑ »ç¶÷µéÀÇ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ÇÇÀÓ¾à ½ÃÀåÀ» ÁÖµµÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¼ºº´ À¯º´·ü Áõ°¡¿Í ÀÎ½Ä Á¦°í·Î ½ÃÀå ¼ºÀå ÃËÁø

»ç¶÷µéÀº ¸ÅÀÏ »ýȰ½À°üÀÇ º¯È­·Î ÀÎÇØ ´Ù¾çÇÑ ÇÕº´Áõ°ú ¹®Á¦¿¡ Á÷¸éÇϰí ÀÖ½À´Ï´Ù. »ýȰ½À°ü¿¡´Â ½Ä½À°ü, ¼ö¸é½Ã°£, ½ÅüȰµ¿, ½ºÆ®·¹½º³ª ºÒ¾È°ú °°Àº ½É¸®»óŰ¡ Æ÷ÇԵǸç, ¼ºº´(STD)Àº ¼¼°è¿¡¼­ Áß¿äÇÑ °Ç°­¹®Á¦À̸ç, WHO¿¡ µû¸£¸é Æò±Õ 25¸í Áß 1¸íÀÌ ¼ºº´À» ¾Î°í ÀÖÀ¸¸ç, ÇÑ °¡Áö ¼ºº´ÀÏ ¼öµµ ÀÖ°í, ¿©·¯ °¡Áö ¼ºº´¿¡ µ¿½Ã¿¡ °¨¿°µÉ ¼öµµ ÀÖ½À´Ï´Ù. Áï, ¼¼°è Àα¸ÀÇ 4%°¡ ¼ºº´À» ¾Î°í ÀÖ´Â ¼ÀÀÔ´Ï´Ù. ÀÌ ½Ã³ª¸®¿À¸¦ ºÐ¼®ÇÑ °á°ú, »ç¶÷µéÀº ¼ºº´¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁ³°í, ¾ÈÀüÀ» À¯ÁöÇϱâ À§ÇØ ´Ù¾çÇÑ ¹æ¹ýÀ» ¼±ÅÃÇÏ°Ô µÇ¾ú½À´Ï´Ù. ÀÌ¿¡ µû¶ó ÇÇÀӾ࿡ ´ëÇÑ ¼ö¿ä´Â ÇâÈÄ ¼ö³â°£ ±ÞÁõÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±¹Á¦±â±¸¿Í °¢±¹ Á¤ºÎ´Â ¼ºº´ÀÇ È®»êÀ» ¸·°í Àα¸ÀÇ ±Þ°ÝÇÑ Áõ°¡¸¦ ¾ïÁ¦Çϱâ À§ÇØ ´Ù¾çÇÑ ÀÎ½Ä °³¼± Ä·ÆäÀΰú ÇÇÀÓ¾à ¹èÆ÷¸¦ ½Ç½ÃÇß½À´Ï´Ù. ¼¼°è °¢±¹ Á¤ºÎ´Â STI ±¹°¡Àü·«°èȹ°ú °°Àº °³º° Ä·ÆäÀÎÀ» ½ÃÇàÇϰí, ÀÌ ºÐ¾ß¿¡¼­ Ȱµ¿ÇÏ´Â NGO¿Í ´Üü¿¡ Àڱݰú º¸Á¶±ÝÀ» Á¦°øÇÏ¿© ¼ºº´À» °ü¸®Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿ìÈ£ÀûÀΠȯ°æÀº ÇÇÀÓ¾àÀÇ ¼ºÀå¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù.

½ÅÈï °æÁ¦±¹°¡ÀÇ Àα¸ ±ÞÁõÀº Á¤ºÎ»Ó¸¸ ¾Æ´Ï¶ó ±¹¹Îµé¿¡°Ôµµ Å« °ü½É»çÀÔ´Ï´Ù. Àεµ¿Í Áß±¹ °°Àº ±¹°¡¿¡¼­´Â °¢ ºÎó°¡ ¿¹¹æ Á¶Ä¡¸¦ ÃëÇÏ°í ¹®Á¦¸¦ ÅëÁ¦Çϱâ À§ÇØ Á¤ºÎ ±â°üÀ» ¼³¸³Çß½À´Ï´Ù. Çö´ëÈ­·Î ÀÎÇØ »ç¶÷µéÀº ÀÏ¿¡ ¸ôµÎÇÏ°í °æ·Â Çü¼ºÀ» À§ÇØ °¡Á· °èȹÀ» äÅÃÇϰí ÀÖÀ¸¸ç, WHO¿¡ µû¸£¸é 2019³â¿¡´Â ¼¼°è¿¡¼­ 19¾ï ¸íÀÇ °¡Àӱ⠿©¼ºÀÌ ÀÖÀ¸¸ç ±× Áß 11¾ï ¸íÀÌ °¡Á· °èȹÀÌ ÇÊ¿äÇÏ´Ù°íÇÕ´Ï´Ù. µû¶ó¼­ Àα¸ ¾ïÁ¦¸¦ À§ÇØ ÇÇÀӾ࿡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÒ °ÍÀÔ´Ï´Ù. ¶ÇÇÑ ³ôÀº Èí¼öÀ², °¡Ã³ºÐ ¼Òµæ Áõ°¡ ½ÃÀå Âü¿©ÀÚÀÇ ³ë·ÂÀº ¿¹Ãø ¿¬µµ¿¡ ÇÇÀӾ࿡ ´ëÇÑ ½ÃÀå ¼ö¿ä¸¦ Áõ°¡½ÃŲ ¿äÀÎÀÔ´Ï´Ù.

ÇÇÀÓ¾àÀ¸·Î ÀÎÇÑ °Ç°­ ¹®Á¦°¡ ¼ºÀåÀ» ¾ïÁ¦

¸ðµç ÀǾàǰÀº º¹¿ëÀ̳ª Ä¡·á¸¦ ¸¶Ä£ ÈÄ ¼ÒºñÀÚ¿¡°Ô ºÎÀÛ¿ëÀ» ÃÊ·¡ÇÕ´Ï´Ù. ÇÇÀÓ¾à »ç¿ëÀ¸·Î ÀÎÇÑ °¨¿° À§Çè Áõ°¡°¡ ºÒÀÓÀ¸·Î À̾îÁú ¼ö ÀÖ´Â °Í°ú ¸¶Âù°¡ÁöÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀεéÀº ÇÇÀÓ¾à ½ÃÀå µµÀÔ¿¡ Àå¾Ö°¡ µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ ¿Ü¿¡µµ »çȸÀû ¼ö¿ë¼º ºÎÁ·°ú ´ëüǰÀ» ¸¸µé·Á´Â °æÀï»ç °£ÀÇ °æÀïÀº ½ÃÀå ¼ºÀå¿¡ ºÎÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¥ ¼ö ÀÖ½À´Ï´Ù.

R&D ÅõÀÚ Áõ°¡

ÇÇÀÓ¾à ½ÃÀåÀÇ È®´ë´Â ½ÅÁ¦Ç° Ãâ½Ã¿Í Á¶Á÷ °£ÀÇ ÀǵµÀûÀÎ Á¦ÈÞ¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÇöÀç ½Ã³ª¸®¿À´Â Çõ½ÅÀûÀÎ Á¦Ç°À» °³¹ßÇÏ°í ¸ÅÃâÀ» ´Ã¸®±â À§ÇØ µÎ Á¶Á÷ÀÇ ¿ª·®À» Ȱ¿ëÇÏ´Â µ¥ µµ¿òÀÌ µÉ °ÍÀÔ´Ï´Ù. ÀÌ ¿Ü¿¡µµ ¼±Áø±¹À» Áß½ÉÀ¸·Î ÇÑ °¡Ã³ºÐ ¼Òµæ Áõ°¡´Â ½ÃÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

½ÃÀå ¼¼ºÐÈ­

¼¼°èÀÇ ÇÇÀӱⱸ ½ÃÀåÀº Á¦Ç° À¯Çü, À¯Åë ä³Î, ÃÖÁ¾»ç¿ëÀÚ¿¡ µû¶ó ¼¼ºÐÈ­µË´Ï´Ù. Á¦Ç° À¯Çüº°·Î´Â Äܵ¼, ´ÙÀ̾îÇÁ·¥, ÀڱðæºÎ ĸ, ½ºÆùÁö, Áú ¸µ, Àڱó» ÇÇÀӱⱸ(IUD), ±âŸ·Î ³ª´¹´Ï´Ù. À¯Åë ä³Î¿¡ µû¶ó ½ÃÀåÀº º´¿ø, ¼Ò¸Å ¾à±¹, ¿Â¶óÀÎ ¾à±¹, ±âŸ·Î ³ª´¹´Ï´Ù. ÃÖÁ¾»ç¿ëÀÚ¿¡ µû¶ó ½ÃÀåÀº ±â¾÷º°·Î ³²¼º¿ë°ú ¿©¼º¿ëÀ¸·Î ³ª´¹´Ï´Ù.

½ÃÀå ±â¾÷

Cooper Surgical, Inc., Pfizer, Inc., Merck &Co Inc., AbbVie, Inc., Teva Pharmaceutical Industries Limited, Ansell Ltd, Bayer AG, Mayer Laboratories Inc., Church &Dwight Co Inc., Reckitt Benckiser Group plc°¡ ÇÇÀӱⱸ ½ÃÀå¿¡¼­ »ç¾÷À» ¿î¿µÇÏ´Â ÁÖ¿ä ±â¾÷ÀÔ´Ï´Ù.

»ç¿ë °¡´ÉÇÑ Ä¿½ºÅ͸¶ÀÌÁ¦À̼Ç

TechSci ¸®¼­Ä¡´Â ÁÖ¾îÁø ½ÃÀå µ¥ÀÌÅ͸¦ ¹ÙÅÁÀ¸·Î ±â¾÷ÀÇ °íÀ¯ÇÑ ¿ä±¸¿¡ µû¶ó ¸ÂÃãÈ­ÇÒ ¼ö ÀÖ½À´Ï´Ù. º¸°í¼­¿¡¼­´Â ´ÙÀ½°ú °°Àº Ä¿½ºÅ͸¶ÀÌÁ¦À̼ÇÀÌ °¡´ÉÇÕ´Ï´Ù. :

±â¾÷ Á¤º¸

  • Ãß°¡ ½ÃÀå Âü¿©ÀÚ(ÃÖ´ë 5°³»ç)¿¡ ´ëÇÑ »ó¼¼ÇÑ ºÐ¼® ¹× ÇÁ·ÎÆÄÀϸµ

¸ñÂ÷

Á¦1Àå °³¿ä

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå COVID-19°¡ ¼¼°èÀÇ ÇÇÀӱⱸ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâ

Á¦5Àå °í°´ÀÇ ¼Ò¸®

Á¦6Àå ¼¼°èÀÇ ÇÇÀӱⱸ ½ÃÀå Àü¸Á

  • ½ÃÀå ±Ô¸ð¡¤¿¹Ãø
    • ±Ý¾×º°
  • ½ÃÀå Á¡À¯À²°ú ¿¹Ãø
    • Á¦Ç° À¯Çüº°
    • À¯Åë ä³Îº°
    • ÃÖÁ¾»ç¿ëÀÚº°
    • ±â¾÷º°
    • Áö¿ªº°
  • ½ÃÀå ¸Ê

Á¦7Àå ºÏ¹ÌÀÇ ÇÇÀӱⱸ ½ÃÀå Àü¸Á

  • ½ÃÀå ±Ô¸ð¡¤¿¹Ãø
    • ±Ý¾×º°
  • ½ÃÀå Á¡À¯À²¡¤¿¹Ãø
    • Á¦Ç° À¯Çüº°
    • À¯Åë ä³Îº°
    • ÃÖÁ¾»ç¿ëÀÚº°
    • ±¹°¡º°
  • ºÏ¹Ì ±¹°¡º° ºÐ¼®
    • ¹Ì±¹
    • ¸ß½ÃÄÚ
    • ij³ª´Ù

Á¦8Àå À¯·´ÀÇ ÇÇÀӱⱸ ½ÃÀå Àü¸Á

  • ½ÃÀå ±Ô¸ð¡¤¿¹Ãø
    • ±Ý¾×º°
  • ½ÃÀå Á¡À¯À²¡¤¿¹Ãø
    • Á¦Ç° À¯Çüº°
    • À¯Åë ä³Îº°
    • ÃÖÁ¾»ç¿ëÀÚº°
    • ±¹°¡º°
  • À¯·´ ±¹°¡º° ºÐ¼®
    • ÇÁ¶û½º
    • µ¶ÀÏ
    • ¿µ±¹
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ

Á¦9Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÇÇÀӱⱸ ½ÃÀå Àü¸Á

  • ½ÃÀå ±Ô¸ð¡¤¿¹Ãø
    • ±Ý¾×º°
  • ½ÃÀå Á¡À¯À²°ú ¿¹Ãø
    • Á¦Ç° À¯Çüº°
    • À¯Åë ä³Îº°
    • ÃÖÁ¾»ç¿ëÀÚº°
    • ±¹°¡º°
  • ¾Æ½Ã¾ÆÅÂÆò¾ç ±¹°¡º° ºÐ¼®
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • Çѱ¹
    • È£ÁÖ

Á¦10Àå ³²¹ÌÀÇ ÇÇÀӱⱸ ½ÃÀå Àü¸Á

  • ½ÃÀå ±Ô¸ð¡¤¿¹Ãø
    • ±Ý¾×º°
  • ½ÃÀå Á¡À¯À²°ú ¿¹Ãø
    • Á¦Ç° À¯Çüº°
    • À¯Åë ä³Îº°
    • ÃÖÁ¾»ç¿ëÀÚº°
    • ±¹°¡º°
  • ³²¹Ì : ±¹°¡º° ºÐ¼®
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
    • ÄÝ·Òºñ¾Æ

Á¦11Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ÇÇÀӱⱸ ½ÃÀå Àü¸Á

  • ½ÃÀå ±Ô¸ð¡¤¿¹Ãø
    • ±Ý¾×º°
  • ½ÃÀå Á¡À¯À²°ú ¿¹Ãø
    • Á¦Ç° À¯Çüº°
    • À¯Åë ä³Îº°
    • ÃÖÁ¾»ç¿ëÀÚº°
    • ±¹°¡º°
  • MEA : ±¹°¡º° ºÐ¼®
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®
    • ÀÌÁýÆ®
    • ÅÍŰ

Á¦12Àå ½ÃÀå ¿ªÇÐ

  • ÃËÁø¿äÀÎ
  • °úÁ¦

Á¦13Àå ½ÃÀå µ¿Çâ°ú ¹ßÀü

Á¦14Àå °æÀï ±¸µµ

  • Cooper Surgical, Inc.
  • Pfizer, Inc
  • Merck & Co Inc
  • AbbVie, Inc
  • Teva Pharmaceutical Industries Limited
  • Ansell Ltd
  • Bayer AG
  • Mayer Laboratories Inc
  • Church & Dwight Co Inc
  • Reckitt Benckiser Group plc.

Á¦15Àå Àü·«Àû Á¦¾È

KSA 23.08.22

The global contraceptive devices market is estimated to increase at an impressive rate through 2027. People use contraceptive devices to avoid pregnancy and infectious diseases spread through their genitals. Contraceptives found in the market include caps, combined pills, contraceptive implants, diaphragms, vaginal rings, intrauterine devices, and a condom. These devices are made for and used by both male and female users. Contraceptive devices act as a physical obstacle preventing sperm from contacting a uterus. Thereby, it helps in restraining insemination and reducing the risk of infection. The rising prevalence of STDs and growing awareness of people's overpopulation control is expected to drive the market for contraceptive devices.

Furthermore, an increase in government initiatives, marketing efforts by the market players, and a rise in disposable income are other factors that are expected to appreciably influence the market's progress through 2027. In 2020, The fertility rate in the United States Fertility Rate was 1.78 per person. The above data shows that people are quite serious about family planning and take precautions to avoid pregnancy. Thus, the United States Contraception market is going to experience growth in the projected year due to their awareness and increasing population.

Rising Prevalence of STDs and Growing Awareness is Propelling the Market

People are facing different complications and problems due to variations in their daily lifestyles. Lifestyle involves diet, sleeping hours, physical activities, and psychological conditions like stress, anxiety, and other problems. STDs (sexually transmitted diseases) are a significant global health issue. According to the WHO, on average, 1 out of 25 people face STDs, which may be one STI or multiple infections at the same time, which means 4% of the global population is suffering from STDs. After analyzing the scenario, people are more aware of the STDs and opt for different methods the keep themselves safe. As a result, the demand for contraceptive devices is expected to swell in the forthcoming years. International agencies and governments worldwide are running different awareness campaigns and distributing contraceptive devices to stop STDs from spreading and controlling the rapid boost of the population. Various governments of the world are running separate campaigns, such as STI National Strategic Plan, and providing funds and grants to NGOs or organizations working in this sector to take control over STDs. This favorable condition is going to impact the growth of contraceptive devices positively.

The rapidly growing population of developing economies is a significant concern for the people as well as the government. Countries like India and China have established government organizations to help the different ministry to take preventive measures and control the problem. Due to modernization, people are busy with their work and are adopting family planning for career building. According to WHO, in 2019, there were 1.9 billion women of reproductive age group globally; out of them, 1.1 billion needed family planning. Thus, the demand for contraceptive devices is going to increase for population control. Additionally, the high absorption rate, rise in disposable income, and effort by the market player are the factor that led to increasing demand for contraceptive devices in the market for a projected year.

Health Issue Associated with Contraceptive Devices is Restraining Growth

Every medicine has side effects on the consumer after completing the dose or treatment. Same as the increased risk of infection involved in the use of a contraceptive device which could lead to infertility. These factors are expected to create hurdles in the adoption of the contraceptive devices market. Apart from these, the lack of social acceptance and competition between the rivals to make the alternative can negatively influence the growth of the market.

Increase in Research and Development Investment

Expansion in the contraceptive devices market is driving the launch of new products and deliberate partnerships among the organizations. The current scenarios will help both organizations to use their competencies to develop innovative products and increase profits. Apart from these, rising disposable income around developed countries is expected to propel the market.

Market Segmentation

The global contraceptive devices market is segmented based on product type, distribution channel, and end user. Based on product type, the market is divided into condoms, diaphragms, cervical caps, sponges, vaginal rings, intrauterine devices (IUDs), and others. Based on distribution channels, the market is divided into hospital pharmacies, retail pharmacies, online pharmacies, and others. Based on end users, the market is split into male and female, by company.

Market Players

Cooper Surgical, Inc., Pfizer, Inc, Merck & Co Inc, AbbVie, Inc, Teva Pharmaceutical Industries Limited, Ansell Ltd, Bayer AG, Mayer Laboratories Inc, Church & Dwight Co Inc, Reckitt Benckiser Group plc are the major player operating in the contraceptive devices Market.

Report Scope

In this report, global Contraceptive Devices Market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Contraceptive Devices Market, By Product Type:

  • Condoms
  • Diaphragms
  • Cervical Caps Sponges
  • Vaginal Rings
  • Intra Uterine Devices (IUDs)
  • Others

Contraceptive Devices Market, By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others

Contraceptive Devices Market, By End User:

  • Male
  • Female

Medical market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • Europe & CIS
    • Germany
    • France
    • United Kingdom
    • Spain
    • Italy
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • Turkey

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global Contraceptive Devices Market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Impact of COVID-19 on Global Contraceptive Devices Market

5. Voice of Customer

6. Global Contraceptive Devices Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product Type (Condoms, Diaphragms, Cervical Caps, Sponges, Vaginal Rings, Intra Uterine Devices (IUDs), Others)
    • 6.2.2. By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others)
    • 6.2.3. By End User (Male v/s Female)
    • 6.2.4. By Company (2021)
    • 6.2.5. By Region
  • 6.3. Market Map

7. North America Contraceptive Devices Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product Type
    • 7.2.2. By Distribution Channel
    • 7.2.3. By End User
    • 7.2.4. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Contraceptive Devices Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product Type
        • 7.3.1.2.2. By Distribution Channel
        • 7.3.1.2.3. By End User
    • 7.3.2. Mexico Contraceptive Devices Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product Type
        • 7.3.2.2.2. By Distribution Channel
        • 7.3.2.2.3. By End User
    • 7.3.3. Canada Contraceptive Devices Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product Type
        • 7.3.3.2.2. By Distribution Channel
        • 7.3.3.2.3. By End User

8. Europe Contraceptive Devices Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product Type
    • 8.2.2. By Distribution Channel
    • 8.2.3. By End User
    • 8.2.4. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Contraceptive Devices Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product Type
        • 8.3.1.2.2. By Distribution Channel
        • 8.3.1.2.3. By End User
    • 8.3.2. Germany Contraceptive Devices Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product Type
        • 8.3.2.2.2. By Distribution Channel
        • 8.3.2.2.3. By End User
    • 8.3.3. United Kingdom Contraceptive Devices Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product Type
        • 8.3.3.2.2. By Distribution Channel
        • 8.3.3.2.3. By End User
    • 8.3.4. Italy Contraceptive Devices Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product Type
        • 8.3.4.2.2. By Distribution Channel
        • 8.3.4.2.3. By End User
    • 8.3.5. Spain Contraceptive Devices Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product Type
        • 8.3.5.2.2. By Distribution Channel
        • 8.3.5.2.3. By End User

9. Asia-Pacific Contraceptive Devices Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product Type
    • 9.2.2. By Distribution Channel
    • 9.2.3. By End User
    • 9.2.4. By Country
  • 9.3. Asia-Pacific: Country Analysis
    • 9.3.1. China Contraceptive Devices Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product Type
        • 9.3.1.2.2. By Distribution Channel
        • 9.3.1.2.3. By End User
    • 9.3.2. India Contraceptive Devices Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product Type
        • 9.3.2.2.2. By Distribution Channel
        • 9.3.2.2.3. By End User
    • 9.3.3. Japan Contraceptive Devices Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product Type
        • 9.3.3.2.2. By Distribution Channel
        • 9.3.3.2.3. By End User
    • 9.3.4. South Korea Contraceptive Devices Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Product Type
        • 9.3.4.2.2. By Distribution Channel
        • 9.3.4.2.3. By End User
    • 9.3.5. Australia Contraceptive Devices Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Product Type
        • 9.3.5.2.2. By Distribution Channel
        • 9.3.5.2.3. By End User

10. South America Contraceptive Devices Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product Type
    • 10.2.2. By Distribution Channel
    • 10.2.3. By End User
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Contraceptive Devices Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product Type
        • 10.3.1.2.2. By Distribution Channel
        • 10.3.1.2.3. By End User
    • 10.3.2. Argentina Contraceptive Devices Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product Type
        • 10.3.2.2.2. By Distribution Channel
        • 10.3.2.2.3. By End User
    • 10.3.3. Colombia Contraceptive Devices Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product Type
        • 10.3.3.2.2. By Distribution Channel
        • 10.3.3.2.3. By End User

11. Middle East and Africa Contraceptive Devices Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Product Type
    • 11.2.2. By Distribution Channel
    • 11.2.3. By End User
    • 11.2.4. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Contraceptive Devices Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Product Type
        • 11.3.1.2.2. By Distribution Channel
        • 11.3.1.2.3. By End User
    • 11.3.2. Saudi Arabia Contraceptive Devices Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Product Type
        • 11.3.2.2.2. By Distribution Channel
        • 11.3.2.2.3. By End User
    • 11.3.3. UAE Contraceptive Devices Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Product Type
        • 11.3.3.2.2. By Distribution Channel
        • 11.3.3.2.3. By End User
    • 11.3.4. Egypt Contraceptive Devices Market Outlook
      • 11.3.4.1. Market Size & Forecast
        • 11.3.4.1.1. By Value
      • 11.3.4.2. Market Share & Forecast
        • 11.3.4.2.1. By Product Type
        • 11.3.4.2.2. By Distribution Channel
        • 11.3.4.2.3. By End User
    • 11.3.5. Turkey Contraceptive Devices Market Outlook
      • 11.3.5.1. Market Size & Forecast
        • 11.3.5.1.1. By Value
      • 11.3.5.2. Market Share & Forecast
        • 11.3.5.2.1. By Product Type
        • 11.3.5.2.2. By Distribution Channel
        • 11.3.5.2.3. By End User

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

  • 14.1. Cooper Surgical, Inc.
  • 14.2. Pfizer, Inc
  • 14.3. Merck & Co Inc
  • 14.4. AbbVie, Inc
  • 14.5. Teva Pharmaceutical Industries Limited
  • 14.6. Ansell Ltd
  • 14.7. Bayer AG
  • 14.8. Mayer Laboratories Inc
  • 14.9. Church & Dwight Co Inc
  • 14.10. Reckitt Benckiser Group plc.

15. Strategic Recommendations

»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦